RCMI Coordinating Center (RCMI CC) Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Singh, Rajesh
Item TypeName
Academic Article Interaction among variant vascular endothelial growth factor (VEGF) and its receptor in relation to prostate cancer risk.
Academic Article CXCL13 mediates prostate cancer cell proliferation through JNK signalling and invasion through ERK activation.
Academic Article PI3Kp110-, Src-, FAK-dependent and DOCK2-independent migration and invasion of CXCL13-stimulated prostate cancer cells.
Academic Article Differential G protein subunit expression by prostate cancer cells and their interaction with CXCR5.
Academic Article Antibody Microarray Analysis of Signaling Networks Regulated by Cxcl13 and Cxcr5 in Prostate Cancer.
Academic Article Molecular basis for prostate cancer racial disparities.
Academic Article CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and av?3 integrin clustering.
Academic Article Andrographolide inhibits prostate cancer by targeting cell cycle regulators, CXCR3 and CXCR7 chemokine receptors.
Academic Article Combinatorial effect of curcumin with docetaxel modulates apoptotic and cell survival molecules in prostate cancer.
Academic Article Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/ p21WAF1/CIP1 and p27KIP1 pathway.
Academic Article Reversal of drug resistance by planetary ball milled (PBM) nanoparticle loaded with resveratrol and docetaxel in prostate cancer.
Academic Article Serum CXCL13 positively correlates with prostatic disease, prostate-specific antigen and mediates prostate cancer cell invasion, integrin clustering and cell adhesion.
Academic Article Clinical and biological significance of CXCR5 expressed by prostate cancer specimens and cell lines.
Concept Prostatic Neoplasms
Academic Article Selective Targeting of the Hedgehog Signaling Pathway by PBM Nanoparticles in Docetaxel-Resistant Prostate Cancer.
Grant Targeted Nanotherapy for prostate cancer
Academic Article Docetaxel Combined with Thymoquinone Induces Apoptosis in Prostate Cancer Cells via Inhibition of the PI3K/AKT Signaling Pathway.
Search Criteria
  • Prostatic Neoplasms
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support